(Q41361182)

29 September 2017

Acute effects of oral alprenolol on exercise tolerance in patients with angina pectoris. A dose-response study (English)

1 reference

29 September 2017

Sealey BJ

1

1 reference

29 September 2017

Liljedal J

series ordinal

2

1 reference

29 September 2017

Nyberg G

series ordinal

3

1 reference

29 September 2017

Ablad B

series ordinal

4

1 reference

29 September 2017

language of work or name

1 reference

1 July 1971

1 reference

29 September 2017

British Heart Journal

1 reference

29 September 2017

33

1 reference

29 September 2017

4

1 reference

29 September 2017

481-488

1 reference

Adrenergic receptors in the coronary circulation

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=487200

The pharmacology of beta-adrenergic blocking agents

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=487200

Alprenolol ("aptin") in angina pectoris. A double-blind multicentre trial

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=487200

Sympathetic control of coronary circulation.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=487200

Effect of beta-adrenergic blockade on coronary blood flow.

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=487200

Treatment of angina pectoris with beta-receptor blockade, mode of action

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=487200

The treatment of angina pectoris with a new beta-receptor blocking agent (H 56/28).

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=487200

Prophylactic treatment of angina pectoris. A double-blind cross-over comparison of alprenolol and pentanitrol.

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=487200

Effect of Propranolol on Systemic and Coronary Hemodynamics at Rest and during Simulated Exercise

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=487200

Effect of free fatty acid on the oxygen consumption of perfused rat heart

19 August 2018

1 reference

12 December 2020

Myocardial vascular reactivity after beta-adrenergic blockade

1 reference

12 December 2020

Hyperdynamic Beta-Adrenergic Circulatory State

1 reference

12 December 2020

Synthesis of some beta-adrenergic blocking agents

1 reference

12 December 2020

Effects of dl-propranolol on myocardial free fatty acid and carbohydrate metabolism

1 reference

12 December 2020

Cardiovascular pharmacology of propranolol in man

1 reference

12 December 2020

Alprenolol in angina pectoris. A clinical and ergometric study with a new beta-adrenergic blocking agent

1 reference

12 December 2020

Effects of three beta adrenergic receptor blockers on myocardial oxygen consumption in the dog

1 reference

12 December 2020

Propranolol and angina pectoris. An analysis of the different responses to the drug in patients with angina pectoris

1 reference

12 December 2020

Identifiers

DOI

10.1136/HRT.33.4.481

1 reference

29 September 2017

1 reference

29 September 2017

PubMed publication ID

4397626

1 reference